Prescription drug · NDA
Photrexa Cross-linking Kit (Riboflavin 5-phosphate ophthalmic) NDC 25357-025
Kit · Glaukos Corporation
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 25357-025-03 | 25357002503 | 2 POUCH in 1 BOX (25357-025-03) / 1 POUCH in 1 POUCH / 1 SYRINGE, GLASS in 1 POUCH / 1 KIT in 1 SYRINGE, GLASSMarketed from Sep 25, 2017 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Photrexa Cross-linking Kit
- Generic name (nonproprietary)
- riboflavin 5-phosphate ophthalmic
- Dosage form
- Kit
- Labeler
- Glaukos CorporationNDC labeler code 25357
- Product type
- Prescription drug
- Marketing category
- NDA — New Drug ApplicationApplication NDA 203324
- Marketing start
- Marketing end
- Identifiers
- Product ID 25357-025_c945d9a7-2e14-41c7-a209-e537aba21749SPL ID c945d9a7-2e14-41c7-a209-e537aba21749SPL set ID f82cfe92-1a24-11e3-8ffd-0800200c9a66RxCUI 1925825, 1925830
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- NDC on a medical claim
N425357002503followed by a unit qualifier and the quantityPackage 25357-0025-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
PHOTREXA ® VISCOUS and PHOTREXA ® are indicated for use in corneal collagen cross-linking in combination with the KXL ® System for the treatment of PHOTREXA VISCOUS and PHOTREXA are photoenhancers indicated for use with the KXL System in corneal collagen cross-linking for the treatment of progressive keratoconus ( 1.1 ) and corneal ectasia following refractive surgery ( 1.2 ). 1.1 Progressive Keratoconus 1.2 Corneal Ectasia Following Refractive Surgery
Excerpt only. Read the full label for complete information.
About NDC 25357-025
- What is NDC 25357-025?
- 25357-025 is the product NDC for Photrexa Cross-linking Kit (riboflavin 5-phosphate ophthalmic) kit, listed with the FDA by Glaukos Corporation. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Photrexa Cross-linking Kit (Riboflavin 5-phosphate ophthalmic).
- Who is the labeler?
- Glaukos Corporation, NDC labeler code 25357. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Photrexa Cross-linking Kit?
- None: this is the only finished product listed under this name.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.